Global lithium battery demand will increase by more than 5 times in 2030
According to a report recently released by the Lithium Bridge Alliance (Li-Bridge), a public and private partnership in the United States, by 2030, the global demand for lithium batteries will surge by more than 5 times.
The report pointed out that compared with the present, the demand for lithium batteries in the United States is expected to increase by more than 6 times by 2030, reaching 55 billion US dollars. The report also expects U.S. supplies to be heavily dependent on imports. At present, the United States lacks a substantial lithium battery supply chain and secure access to energy materials, and less than 30% of the batteries consumed in the country are supplied by domestic companies.
Li-Bridge is an institution led by the Argonne National Laboratory funded by the US Department of Energy in 2021. The agency aims to accelerate the establishment of a robust lithium battery supply chain by building bridges between the public and private sectors to bridge the gap between battery supply and growing demand.
Looking for chemical products? Let suppliers reach out to you!
2026-06-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Supporting Each Other | ECHEMI Employees Voluntarily Raise Funds for Flood Relief in Southern Thailand
-
Notice of 2026 Chinese New Year Holiday
-
Address Change Declaration(ECHEMI SPECIALTIES)
-
China’s API Export Shift Takes Center Stage at API China 2026
-
New Location, New Horizon: ECHEMI Thailand Branch Embarks on a New Chapter
-
International Workers' Day Holiday Notice and Service Arrangement
-
ICIS Global No.58: ECHEMI Again Ranks Among the World’s Chemical Distributors
Recommend Reading
-
Léa Nature Acquires Berdoues to Enter the Fragrance Market
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
CYNiO Receives Over €2 Million for the NextInnovation in the Specialty Chemicals Industry
-
A Cold-Chain Crackdown in Delhi Sends a Much Bigger Message
-
China’s Approval of Pfizer’s GLP-1 Drug Signals a Sharper Obesity Race